Financhill
Back

Milestone Pharmaceuticals, Inc. Vs. Corcept Therapeutics, Inc. Industry Stock Comparison

Sell
43

MIST
Milestone Pharmaceuticals, Inc.

Last Price:
$2.02
Seasonality Move:
-24.48%
Sell
30

CORT
Corcept Therapeutics, Inc.

Last Price:
$34.79
Seasonality Move:
13.21%
Sell
43
Milestone Pharmaceuticals, Inc. (MIST) is a Sell

Is Milestone Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Milestone Pharmaceuticals, Inc. [MIST] share price is $1.96. The Score for MIST is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • MIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Corcept Therapeutics, Inc. (CORT) is a Sell

Is Corcept Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Corcept Therapeutics, Inc. [CORT] share price is $34.80. The Score for CORT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CORT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MIST Stock Price Chart

What is Milestone Pharmaceuticals, Inc.'s stock price today?

  • The Milestone Pharmaceuticals, Inc. share price today is $1.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIST is experiencing slight buying pressure.

CORT Stock Price Chart

What is Corcept Therapeutics, Inc.'s stock price today?

  • The Corcept Therapeutics, Inc. share price today is $34.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing slight selling pressure.

MIST Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 38.05 Sell
Chaikin Money Flow: -3945520 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CORT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.88 Sell
Relative Strength Index (14 RSI): 14.83 Sell
Chaikin Money Flow: -8077532 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (70.63 - 90.59) Sell
Bollinger Bands (100): (69.66 - 84.14) Sell

MIST Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.05 Sell
20-day SMA: 2.35 Sell
50-day SMA: 2.18 Sell
200-day SMA: 1.76 Buy
8-day EMA: 2.08 Sell
20-day EMA: 2.21 Sell
50-day EMA: 2.05 Sell
200-day EMA: 1.02 Buy

CORT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.24 Sell
20-day SMA: 80.76 Sell
50-day SMA: 77.62 Sell
200-day SMA: 73.92 Sell
8-day EMA: 69.79 Sell
20-day EMA: 76.79 Sell
50-day EMA: 77.19 Sell
200-day EMA: 51.2 Sell

Milestone Pharmaceuticals, Inc. Earnings Growth & MIST Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and a decrease next year of $0.31 per share.

Corcept Therapeutics, Inc. Earnings Growth & CORT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $3.04 per share.

Milestone Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corcept Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):